News & Events

  • Toxic Metals in Baby Food ‘Concerning’ for Researchers
    2/3/23

    Rice cereal, formula, purees and puffs. They’re among the most popular products purchased from the baby food aisle. And they share one more thing in common: They likely contain toxic metals.

  • Omicron Caused Fewer Cases of MIS-C in Kids Than Delta
    1/19/23

    A new Jacobs School of Medicine and Biomedical Sciences study conducted at Oishei Children’s Hospital is one of the first to reveal that there were fewer cases of multi-system inflammatory syndrome in children (MIS-C) during the omicron wave of the pandemic than the delta wave.

  • Gun Violence, Racism Topics of ‘Beyond the Knife’ Lecture
    1/13/23

    “I don’t feel that we can talk about gun violence in this country without talking about race,” he said. “Why do I say that? We need to look at who is harmed by gun violence and who is protected. Which stories are elevated and which are minimized.”

  • NEJM Publishes Two Major Papers by Pediatrics Faculty
    12/19/22

    Getting a paper published in the New England Journal of Medicine (NEJM) is a career-crowning achievement for any medical researcher. This fall, within one week, it happened to two members of the Department of Pediatrics in the Jacobs School of Medicine and Biomedical Sciences, both of whom also happen to be Jacobs School alumnae.

  • 19 Faculty Members Join 6 Medical School Departments
    12/16/22

    Nineteen faculty members with clinical and research experience have joined the departments of Medicine, Obstetrics and Gynecology, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, and Physiology and Biophysics.

  • COVID-19 and the Holidays: Advice on How to Stay Safe
    12/14/22

    As the holiday season kicks into high gear, Jacobs School of Medicine and Biomedical Sciences physicians and scientists have recommendations for how people can stay safe and healthy this holiday season amid some increasingly concerning signs.

  • Dramatic Weight Loss in Trial for Teens With Obesity
    11/30/22

    For teens who have struggled with obesity, it probably sounded too good to be true: a weekly injection that could help them control their eating and lead to weight loss. But the results of the clinical trial on the drug semaglutide, released earlier this month in the New England Journal of Medicine and presented at the discipline’s major conference, Obesity Week, turned out to be better than anything the participants — or even the researchers — expected.

  • Pediatric Respiratory Infections, Flu Cases Surging
    11/28/22

    The request by children’s hospitals nationwide this month that the federal government declare a formal state of emergency given the surge in respiratory syncytial virus (RSV) and flu cases was no surprise to Oscar G. Gómez, MD, PhD, associate professor of pediatrics.

  • SUNY Diversity in Medicine Award Goes to Jarvis, Milling, Perez
    11/28/22

    Three members of the Jacobs School of Medicine and Biomedical Sciences faculty have been honored with SUNY Diversity in Medicine Mentoring Awards.

  • Pediatric Diabetes Research Team Lauded for its Work
    11/22/22

    Kathleen E. Bethin, MD, PhD, clinical professor of pediatrics and her research team have been lauded by the Pediatric Diabetes Consortium (PDC) for their contributions to the PIONEER TEENS clinical trial sponsored by the Danish pharmaceutical company Novo Nordisk.

  • Black Men in White Coats Chapter Established at UB
    11/7/22

    A Black Men in White Coats chapter has been established at the Jacobs School of Medicine and Biomedical Sciences and is named in honor of the late Jonathan D. Daniels, MD ’98, the school’s former associate director of admissions who died July 4 in a fire at his North Buffalo home.

  • NIH Grant Aims to Boost Newborn Screening Accuracy
    11/6/22

    “Your baby has a genetic disease.” It’s one of the most terrifying things that new parents can hear. Yet it frequently turns out not to be true because, while newborn screening is extremely accurate for many common conditions, screening accuracy rates for rare — even fatal — conditions can be abysmal, according to genetics specialists.